Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 5NSCLC 2Neoplasms, Second Primary 1Lung Neoplasms 1Adenocarcinoma 1

Interventions

icotinib 2anlotinib 2Drug Therapy 2lorlatinib 1Thalidomide 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × NSCLC × icotinib × Clear all
NCT02404675 2017-07-28

INCREASE

Betta Pharmaceuticals Co., Ltd.

Phase 4 Unknown
240 enrolled
Thoracic

NSCLC

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown
67 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡